KIN
Kindred Biosciences, Inc.
KIN
KIN
Delisted
KIN was delisted on the 27th of August, 2021.
63 hedge funds and large institutions have $153M invested in Kindred Biosciences, Inc. in 2018 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 24 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
38% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 24
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $484K
Holders
63
Holding in Top 10
1
Calls
–
Puts
$484K
Top Buyers
| 1 | +$1.12M | |
| 2 | +$894K | |
| 3 | +$472K | |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$335K |
| 5 |
Citigroup
New York
|
+$258K |
Top Sellers
| 1 | -$2.56M | |
| 2 | -$1.68M | |
| 3 | -$872K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$810K |
| 5 |
AFS
Amtrust Financial Services
New York
|
-$612K |